Conclusion Of Non-Exclusive Discount Agreements According To §§ 130A Abs. 8/130C Abs. 1 Sgb V For Drugs With The Active Ingredient Formoterol And Aclidinium Bromide (R03Al05) As Part Of An Open House Model.